StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.56−0.02 (-3.76%)

Close on Nov 19, 2026Market cap $13.12MP/E –Yield –

Genenta Science S.p.A. shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 20M, up 7.9% from the year before. The highest annual figure on record is 20M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202520M+7.9%
FY2024Dec 31, 202418M+0.3%
FY2023Dec 31, 202318M+0.0%
FY2022Dec 31, 202218M+20.8%
FY2021Dec 31, 202115M–

More Genenta Science S.p.A. figures

See a number that looks wrong?